Target intelligence / Profile preview

Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 11 (MTND2P11)

Target
MTND2P11
Molecular classification
Other, Pseudogene
01

Overview

MTND2P11, or "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 11," is a human nuclear pseudogene located at 9q31.3 that is related by sequence to the mitochondrial gene MT-ND2, which encodes a subunit of respiratory chain Complex I. As a pseudogene, MTND2P11 does not produce a functional protein, is not known to perform biological functions, and is not considered a therapeutic target or disease gene. The gene is cataloged as a pseudogene by the HUGO Gene Nomenclature Committee and is not associated with drug action or clinical biomarkers[2][4]. Context and Explanation: - MTND2P11 is explicitly described as a "pseudogene" by authoritative gene nomenclature resources[2][4]. - Pseudogenes are non-functional genomic DNA sequences similar to normal genes but typically lack the ability to code for a functional protein[2][4]. - There is currently no evidence that MTND2P11 encodes an active protein, serves as a biomarker, is involved in biological processes, or has a role in disease, drug interaction, or therapeutic action. - Its parent gene, MT-ND2, is a well-characterized mitochondrial gene involved in oxidative phosphorylation and disease, but MTND2P11 itself does not share these functions[1][2][3]. - Some mitochondrial pseudogenes (including others in the MT-ND family) are expressed in certain tissues and may be used in gene expression studies as markers of altered transcription—the direct clinical or mechanistic relevance for MTND2P11 remains unestablished and speculative at this time[5]. Notes about is_incorrect: - This is not a drug target, receptor, enzyme, transporter, or active molecular entity used in therapy or mechanistic studies. - If the query intends to find a druggable or functional mitochondrial gene, MT-ND2 (not MTND2P11) is the appropriate entity[1][3]. - No interacting drugs, mechanism of action, biomarker use, or disease linkage is documented for MTND2P11[2][4][5].

Other names
MT-ND2 pseudogene 11MTND2P11

Beyond the preview

Go deeper on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 11 (MTND2P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 11 (MTND2P11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call